P. Gumbs

Deep Vein Thrombosis in Europe—Health-Related Quality of Life and Mortality

S. Willich, A. Gitt, A. Cohen, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries

A. Gitt, A. Cohen, G. Agnelli, 2019, Quality of Life Research.

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK

P. Verhamme, A. Cohen, E. Clay, 2016, Journal of market access & health policy.

Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work.

S. Willich, A. Cohen, G. Agnelli, 2018, Thrombosis research.

Deep-vein thrombosis in Europe - Burden of illness in relationship to healthcare resource utilization and return to work.

S. Willich, A. Gitt, A. Cohen, 2018, Thrombosis research.

The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey

H. Rümke, P. Gumbs, J. H. Wolleswinkel-van den Bosch, 2011, BMC infectious diseases.

Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands

M. Postma, Pauline CE Van Steenwijk, P. Gumbs, 2012, BMC Infectious Diseases.

Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.

P. Souverein, A. de Boer, O. Klungel, 2007, British journal of clinical pharmacology.

Economic Evaluations of Cholesterol-Lowering Drugs

M. Verschuren, O. Klungel, A. Mantel‐Teeuwisse, 2012, PharmacoEconomics.

The impact of co-morbidity on the disease burden of VTE

S. Willich, A. Gitt, A. Cohen, 2018, Journal of Thrombosis and Thrombolysis.

Drug Costs Associated with Non-Adherence to Cholesterol Management Guidelines for Primary Prevention of Cardiovascular Disease in an Elderly Population

A. Hofman, B. Stricker, O. Klungel, 2006, Drugs & aging.

Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis

S. Willich, A. Gitt, A. Cohen, 2019, Quality of Life Research.

Economic evaluations of cholesterol-lowering drugs: a critical and systematic review.

A. de Boer, M. Verschuren, O. Klungel, 2007, PharmacoEconomics.